Skip to content

Mobile Phone Reminders (and Photovoice) for Routine Immunization in Nigeria - The MOPING Study

EFFICACY OF MOBILE PHONE REMINDERS (AND PHOTOVOICE) IN IMPROVING CHILDHOOD IMMUNIZATION UPTAKE AND REDUCING INCIDENCE OF VACCINE-PREVENTABLE DISEASES - A RANDOMIZED CONTROLLED TRIAL AMONG POSTPARTUM MOTHERS AND CAREGIVERS IN NIGERIA

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03402646
Acronym
MOPING
Enrollment
1813
Registered
2018-01-18
Start date
2018-05-31
Completion date
2019-12-31
Last updated
2018-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immunization; Infection

Brief summary

This study aims to implement and test the efficacy of photovoice, Short Messaging Service (SMS) and phone call reminders in improving childhood immunization coverage (uptake, timeliness and completion rates) and reducing incidence of vaccine-preventable diseases (VPDs) among infants in Nigeria

Detailed description

This will be a single-blind three-arm cluster randomized controlled trial involving post-partum mothers and/or caregivers of infants (age 0-12months) attending immunization clinics in 12 randomly selected Primary Health Care Centres (clusters) across Sokoto, Jigawa, Kano, Ogun, Oyo and Lagos States of Nigeria. Additionally, a photovoice methodology will be implemented in 6 community clusters (one in each State) involving group discussions between community members (pregnant women in their third trimester, parents/caregivers of infants age 0-12 months), community leaders, service providers and policy makers on benefits of timely immunization and consequences of non-vaccination. Parent-infant pairs will be followed up for 12 months during which SMS and phone call immunization clinic appointment reminders will be provided to mothers and/or caregivers in intervention arm 1, and photovoice intervention provided at study commencement to participants in intervention arm 2. Respondents in the control group would receive standard care (routine paper-based appointment scheduling alone). The investigators will document and compare immunization uptake (all doses and vaccines), timeliness of receipt and completion rates of scheduled immunization between the three groups, as well as incidence of VPDs between the groups using multivariate statistical analyses.

Interventions

BEHAVIORALReminder module (SMS and Phone call)

Same as described under arm/group descriptions

BEHAVIORALPhotovoice

Same as described under arm/group descriptions

Sponsors

RCSI & UCD Malaysia Campus
CollaboratorOTHER
Universiti Putra Malaysia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Investigator, Outcomes Assessor)

Intervention model description

This will be a single-blind three-arm cluster randomized controlled trial involving post-partum mothers and/or caregivers of infants (age 0-12months) attending immunization clinics in 12 randomly selected Primary Health Care Centres (clusters) across Sokoto, Jigawa, Kano, Ogun, Oyo and Lagos States of Nigeria. Additionally, the investigators will be implementing a photovoice methodology in 6 community clusters (one in each State) involving group discussions between community members (pregnant women in their third trimester, parents/caregivers of infants age 0-12 months), community leaders, service providers and policy makers on benefits of timely immunization and consequences of non-vaccination.

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Mothers/caregivers of healthy infants (age 0 - 12 months) who: 1. Have a mobile phone access 2. Received antenatal care and/or delivered their babies in a hospital 3. Plans to receive immunizations at the selected PHCs * Purposively-selected community sample of pregnant women in their third trimester, parents/caregivers of infants, providers, community gatekeepers and policy makers

Exclusion criteria

1. Parents of infants requiring hospital admission due to significant illness, congenital deformity/malformation and prematurity 2. Foreigners

Design outcomes

Primary

MeasureTime frameDescription
Immunization coverage12 monthsProportion of randomized infants who received birth doses of BCG and OPV (overall), and complete doses of each vaccine as scheduled
Timeliness of receipt of scheduled immunization12 monthsProportion of infants receiving scheduled immunization within 1 week of schedule

Secondary

MeasureTime frameDescription
Incidence of any childhood vaccine-preventable disease12 monthsRisk ratio of vaccine-preventable disease between intervention and control groups

Contacts

Primary ContactSurajudeen A Abdulrahman, MBBS, PhD
abdulsuraj@gmail.com+60167067760

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026